Caretha Coleman Biography and Net Worth

Director of RealReal

Caretha Coleman has served on our board of directors since August 2020. Ms. Coleman currently is Principal of Coleman Consulting and serves as Chairman of Dignity Community Care, which is now part of the merged CommonSpirit Health, and as Board Member of Virdris Learning.

She brings more than 40 years of experience in the technology industry working with early stage ventures to public companies on organizational strategy development and executive coaching and effectiveness. Among her accomplishments is Software Publishing Corporation, where she played an integral role, as Chief Human Resources Officer, in pioneering one of the earliest successful desktop computer software businesses. As one of Silicon Valley’s first female technology executives of color, Ms. Coleman has spent decades advocating for women and minorities in business and cultivating diverse communities outside of the workplace.

Ms. Coleman serves as the Chair of The RealReal's Compensation, Diversity and Inclusion Committee.

What is Caretha Coleman's net worth?: The estimated net worth of Caretha Coleman is at least $2.46 million as of May 31st, 2024. Coleman owns 174,833 shares of RealReal stock worth more than $2,456,404 as of December 4th. This net worth evaluation does not reflect any other investments that Coleman may own. Learn More about Caretha Coleman's net worth.
How do I contact Caretha Coleman?: The corporate mailing address for Coleman and other RealReal executives is 55 FRANCISCO STREET SUITE 600, SAN FRANCISCO CA, 94133. RealReal can also be reached via phone at (855) 435-5893 and via email at [email protected]. Learn More on Caretha Coleman's contact information.
Has Caretha Coleman been buying or selling shares of RealReal?: Caretha Coleman has not been actively trading shares of RealReal during the past quarter. Most recently, Caretha Coleman sold 10,354 shares of the business's stock in a transaction on Friday, May 31st. The shares were sold at an average price of $4.33, for a transaction totalling $44,832.82. Following the completion of the sale, the director now directly owns 174,833 shares of the company's stock, valued at $757,026.89. Learn More on Caretha Coleman's trading history.
Who are RealReal's active insiders?: RealReal's insider roster includes Caretha Coleman (Director), Luke Friang (Insider), Matt Gustke (CFO), Arnon Katz (Insider), Karen Katz (Director), John Koryl (CEO), Robert Krolik (Director), Rati Levesque (President), Steve Lo (CAO), Gopal Madan (CFO), James Miller (Director), Levesque Sahi (President), Todd Suko (Insider), and Julie Wainwright (CEO). Learn More on RealReal's active insiders.
Are insiders buying or selling shares of RealReal?: During the last twelve months, insiders at the sold shares 19 times. They sold a total of 16,889,300 shares worth more than $218,092,110.38. The most recent insider tranaction occured on November, 26th when CFO Gopal Ajay Madan sold 28,520 shares worth more than $420,099.60. Insiders at RealReal own 9.0% of the company. Learn More about insider trades at RealReal.
Information on this page was last updated on 11/26/2025.

Caretha Coleman Insider Trading History at RealReal

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/31/2024	Sell	10,354	$4.33	$44,832.82	174,833

Caretha Coleman Buying and Selling Activity at RealReal

RealReal Company Overview

The RealReal, Inc. operates an online marketplace for resale luxury goods in the United State. The company offers various product categories, including women's fashion, men's fashion, jewelry, and watches. It primarily sells products through online marketplace and retail stores. The company was incorporated in 2011 and is headquartered in San Francisco, California.

Today's Range

Now: $14.21

$13.99

$14.54

50 Day Range

MA: $12.20

$9.45

$15.48

2 Week Range

Now: $14.21

$4.61

$16.24

Volume

1,908,681 shs

Average Volume

4,484,145 shs

Market Capitalization

$1.66 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.68